Qt Imaging Holdings (QTI) Cash from Restructuring (2024)

Qt Imaging Holdings (QTI) reported Cash from Restructuring of -$20349.0 for Q4 2024, down 656.74% quarter-over-quarter from $3655.0 in Q2 2024.

Qt Imaging Holdings (QTI) Cash from Restructuring (2024) Analysis & Trends

Qt Imaging Holdings (QTI) has 1 years of Cash from Restructuring data on file, last reported at -$20349.0 in Q4 2024.

Cash from Restructuring for Q4 2024 came in at -$20349.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$20349.0 (down 100.55% YoY), and the FY2024 annual result was $3.7 million, changed N/A from the prior year.
Cash from Restructuring declined to -$20349.0 in Q4 2024 per QTI's latest filing, from $3655.0 in the prior quarter.
Over five years, Cash from Restructuring peaked at $3.7 million in Q1 2024 and troughed at -$20349.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Qt Imaging Holdings	51.33 Mn	51.33 Mn	2.67 Mn

Download Data